The sporadic form of Alzheimer's disease (AD) represents most of the clinical cases for AD
and at least ten percent of the global population over the age of 65 are affected by sporadic …

Apolipoprotein E4 (APOE4) is one of the primary genetic risk factors for late-onset of
Alzheimer's disease (AD). While its primary function is to transport cholesterol, it also …

COVID-19, which primarily affects the pulmonary system, turned out to be a global
pandemic, whereas the effects on other systems are still unknown. SARS-CoV-2, binds to …

APOE ε4 polymorphism has been recently described as a possible association with
cognitive deficits in COVID-19 patients. This research aimed to establish the correlation …

Apolipoprotein E ε4 allele (APOE4) has been shown to associate with increased
susceptibility to SARS-CoV-2 infection and COVID-19 mortality in some previous genetic …

Challenges have been recognized in healthcare of patients with Alzheimer's disease (AD) in
the COVID-19 pandemic, given a high infection and mortality rate of COVID-19 in these …

COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …

Alzheimer's disease (AD) is a life-changing condition whose etiology is explained by several
hypotheses. Recently, a new virus contributed to the evidence of viral involvement in AD: the …

Abstract Coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially …

Background Dementia-like cognitive impairment is an increasingly reported complication of
SARS-CoV-2 infection. However, the underlying mechanisms responsible for this …